Literature DB >> 32184058

Characteristics of the microbiota in the urine of women with type 2 diabetes.

Sue Penckofer1, Robert Limeira2, Cara Joyce2, Meghan Grzesiak3, Krystal Thomas-White2, Alan J Wolfe2.   

Abstract

PURPOSE: The urinary microbiota in women with type 2 diabetes (T2DM) can have bacterial uropathogens which are more virulent. The primary objective was to describe and compare the characteristics of the microbiota in voided urine of women with and without T2DM.
METHODS: Two cohorts of women: those with T2DM (n = 87) and those without T2DM (n = 49) were studied. Demographic data, hemoglobin A1c (HbA1c), fasting serum glucose, and voided urine were collected. To determine the characteristics of the microbiota in the urine, 16S rRNA gene sequencing was used.
RESULTS: The genus Lactobacillus was more often present in women with T2DM (75.9%, n = 66) than in the controls (59.2%, n = 30) (p = 0.042), as was the family Enterobacteriaceae (12.6% T2DM versus 2.0% control, p = 0.055). There was evidence of an association between HbA1c and the relative abundance of the various bacteria in the total cohort. The relative abundance of Lactobacillus was positively associated (ρ = 0.19, 95% CI: 0.02, 0.34), while Corynebacterium (ρ = -0.26, 95% CI: -0.41, -0.10) and Prevotella (ρ = -0.23, 95% CI: -0.38, -0.06) were inversely associated with HbA1c.
CONCLUSIONS: Enterobacteriaceae (e.g. E. coli) predispose women to urinary tract infections and since T2DM increases this risk, further study is needed. The species of Lactobacillus and its impact needs exploration.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Year:  2020        PMID: 32184058      PMCID: PMC7329247          DOI: 10.1016/j.jdiacomp.2020.107561

Source DB:  PubMed          Journal:  J Diabetes Complications        ISSN: 1056-8727            Impact factor:   2.852


  30 in total

1.  Urine is not sterile: use of enhanced urine culture techniques to detect resident bacterial flora in the adult female bladder.

Authors:  Evann E Hilt; Kathleen McKinley; Meghan M Pearce; Amy B Rosenfeld; Michael J Zilliox; Elizabeth R Mueller; Linda Brubaker; Xiaowu Gai; Alan J Wolfe; Paul C Schreckenberger
Journal:  J Clin Microbiol       Date:  2013-12-26       Impact factor: 5.948

2.  Risk characterization for urinary tract infections in subjects with newly diagnosed type 2 diabetes.

Authors:  Alex Z Fu; Kristy Iglay; Ying Qiu; Samuel Engel; Ravi Shankar; Kimberly Brodovicz
Journal:  J Diabetes Complications       Date:  2014-06-17       Impact factor: 2.852

3.  Urinary microbes and postoperative urinary tract infection risk in urogynecologic surgical patients.

Authors:  Krystal J Thomas-White; Xiang Gao; Huaiying Lin; Cynthia S Fok; Kathryn Ghanayem; Elizabeth R Mueller; Qunfeng Dong; Linda Brubaker; Alan J Wolfe
Journal:  Int Urogynecol J       Date:  2018-09-28       Impact factor: 2.894

4.  Bacterial virulence phenotypes of Escherichia coli and host susceptibility determine risk for urinary tract infections.

Authors:  Henry L Schreiber; Matt S Conover; Wen-Chi Chou; Michael E Hibbing; Abigail L Manson; Karen W Dodson; Thomas J Hannan; Pacita L Roberts; Ann E Stapleton; Thomas M Hooton; Jonathan Livny; Ashlee M Earl; Scott J Hultgren
Journal:  Sci Transl Med       Date:  2017-03-22       Impact factor: 17.956

5.  Urinary bacteria in adult women with urgency urinary incontinence.

Authors:  Linda Brubaker; Charles W Nager; Holly E Richter; Anthony Visco; Ingrid Nygaard; Matthew D Barber; Joseph Schaffer; Susan Meikle; Dennis Wallace; Noriko Shibata; Alan J Wolfe
Journal:  Int Urogynecol J       Date:  2014-02-11       Impact factor: 2.894

6.  Bacterial characteristics and glycemic control in diabetic patients with Escherichia coli urinary tract infection.

Authors:  Ming-Cheng Wang; Chin-Chung Tseng; An-Bang Wu; Wei-Hung Lin; Ching-Hao Teng; Jing-Jou Yan; Jiunn-Jong Wu
Journal:  J Microbiol Immunol Infect       Date:  2012-05-07       Impact factor: 4.399

Review 7.  A comprehensive review of urologic complications in patients with diabetes.

Authors:  Fernando Arrellano-Valdez; Marta Urrutia-Osorio; Carlos Arroyo; Elena Soto-Vega
Journal:  Springerplus       Date:  2014-09-23

8.  Prevalence and risk factors for urinary incontinence in overweight and obese diabetic women: action for health in diabetes (look ahead) study.

Authors:  Suzanne Phelan; Alka M Kanaya; Leslee L Subak; Patricia E Hogan; Mark A Espeland; Rena R Wing; Kathryn L Burgio; Vicki Dilillo; Amy A Gorin; Delia S West; Jeanette S Brown
Journal:  Diabetes Care       Date:  2009-06-01       Impact factor: 19.112

9.  Association between the vaginal microbiota, menopause status, and signs of vulvovaginal atrophy.

Authors:  Rebecca M Brotman; Michelle D Shardell; Pawel Gajer; Doug Fadrosh; Kathryn Chang; Michelle I Silver; Raphael P Viscidi; Anne E Burke; Jacques Ravel; Patti E Gravitt
Journal:  Menopause       Date:  2014-05       Impact factor: 3.310

10.  Characterization of the urinary microbiota of elderly women and the effects of type 2 diabetes and urinary tract infections on the microbiota.

Authors:  Fengping Liu; Zongxin Ling; Yonghong Xiao; Qing Yang; Li Zheng; Ping Jiang; Lanjuan Li; Wei Wang
Journal:  Oncotarget       Date:  2017-09-21
View more
  3 in total

1.  UPΦ phages, a new group of filamentous phages found in several members of Enterobacteriales.

Authors:  Jason W Shapiro; Catherine Putonti
Journal:  Virus Evol       Date:  2020-06-22

2.  Multiple bacteria associated with the more dysbiotic genitourinary microbiomes in patients with type 2 diabetes mellitus.

Authors:  Hua Zha; Fengping Liu; Zongxin Ling; Kevin Chang; Jiezuan Yang; Lanjuan Li
Journal:  Sci Rep       Date:  2021-01-19       Impact factor: 4.379

3.  Application of machine learning tools: Potential and useful approach for the prediction of type 2 diabetes mellitus based on the gut microbiome profile.

Authors:  Xiaochun Ge; Aimin Zhang; Lihui Li; Qitian Sun; Jianqiu He; Yu Wu; Rundong Tan; Yingxia Pan; Jiangman Zhao; Yue Xu; Hui Tang; Yu Gao
Journal:  Exp Ther Med       Date:  2022-02-23       Impact factor: 2.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.